
Unreasonable Labs
Building foundational AI superintelligence to accelerate scientific knowledge discovery and breakthroughs across complex domains.
About
Unreasonable Labs builds AI that discovers new knowledge and solves hard problems by integrating science, technology, art, and human intuition. Their AI discovery engine, Unreasonable.DISCOVERY, helps users compose new knowledge across disciplines by creating a unified world model that connects fragmented information and enables deep reasoning for insight generation. This empowers innovation across scientific and technological frontiers by making experts faster and smarter.
Listed competitors
Anthropic is an AI safety and research public benefit corporation building reliable, interpretable, and steerable AI systems, best known for the Claude series of advanced AI models.
AI-powered biotech platform using protein design to discover novel therapeutic molecules for hard-to-treat targets.
AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.
OpenAI is an AI research and deployment company dedicated to ensuring that artificial general intelligence benefits all of humanity.
“OpenAI is not going to win because they have the best models, or the most advanced chips, or the best cost-performance curve, or even the…” r/codex
Also in this space
AI-powered research assistant for scientific literature review and data extraction.
Shares Artificial Intelligence, Biotechnology
AI company using federated learning to solve biological complexity and accelerate drug discovery.
Shares Artificial Intelligence, Biotechnology
AI-driven predictive modeling company focused on biology and life sciences.
Shares Artificial Intelligence, Biotechnology
AI-guided drug discovery platform for tissue-targeted medicines.
Shares Biotech, Drug Discovery
A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.
Shares Biotechnology, Drug Discovery
AI platform for engineering molecular glues to create a new class of medicines.
Shares Biotechnology, Artificial Intelligence
Key facts
- Website
- unreasonablelabs.ai
- Headquarters
- Cambridge, Massachusetts, United States
- Founded
- 2023
- Total funding
- $14M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 10 Mar 2026 | Seed | $14M | Playground Global |
Tech stack
Detected on unreasonablelabs.ai, last scanned 22 Oct 2026. Run your own scan
- Email provider
- Google Workspace
Unreasonable Labs scores 9. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
How much funding has Unreasonable Labs raised?
Unreasonable Labs has raised a total of $14M in funding. The most recent round on record is Seed.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Unreasonable Labs

